Year: 2013
Type: article
Abstract: importance-that will depend on the magnitude of the effect, and the therapeutic range of the target drug.In any case, the modification of therapeutic plans for renal failure patients is not a matter of kinetics alone.Such patients may be taking multiple medications, be generally debilitated, or have intrinsically altered sensitivity to certain drugs.We encourage ongoing discussion of a regulatory position that both encourages drug development and assures patient welfare.
DOI: 10.1002/cpdd.70
Author: David J. Greenblatt
Institution: Tufts University
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W1576868446
